Stockscreener 앱 받기
404.94
2.37%
-9.81
시간 외 거래:
416.00
11.06
+2.73%
전일 마감가:
$414.75
열려 있는:
$414.94
하루 거래량:
2.73M
Relative Volume:
1.00
시가총액:
$152.86B
수익:
$42.90B
순이익/손실:
$6.52B
주가수익비율:
23.75
EPS:
17.05
순현금흐름:
$6.72B
1주 성능:
-4.80%
1개월 성능:
+1.77%
6개월 성능:
-29.34%
1년 성능:
-24.22%
1일 변동 폭
$403.36
$415.00
1주일 범위
$403.36
$429.00
52주 변동 폭
$385.46
$627.88
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Thermo Fisher Scientific accelerates precision oncology research - Scientist Live
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher - Yahoo Finance
What drives Thermo Fisher Scientific Inc. stock priceSkyrocketing profit margins - jammulinksnews.com
What analysts say about Thermo Fisher Scientific Inc. stockFast-track wealth growth - Autocar Professional
Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentHigh-impact investment strategies - Autocar Professional
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi - Insider Monkey
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - MSN
Thermo Fisher Scientific's Q2 2025 Earnings: Navigating Near-Term EPS Pressures With a High-Innovation Engine - AInvest
Thermo Fisher Scientific's Q2 2025 Earnings Outlook: Assessing Growth Resilience Amid EPS Declines and Strategic Momentum in Key Verticals - AInvest
Thermo Fisher Scientific Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - MSN
Lobbying Update: $400,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2025 Earnings Call Transcript - MSN
Thermo Fisher Scientific Trading Volume Ranks 84th Amid Price Target Cut - AInvest
Thermo Fisher (TMO) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance
13 Best Long Term Low Volatility Stocks to Buy Now - Insider Monkey
Pharma Contract Research Organization (CRO) Services Market to Cross USD 36.66 Billion in 2025, Expanding at a CAGR of 10.04% - GlobeNewswire Inc.
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus - TradingView
How the Digital Genome Market Will Evolve by 2032Growth, - openPR.com
Thermo Fisher and Sanofi Expand Strategic Partnership to Enable US Drug Manufacturing - CHEManager
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - GlobeNewswire
Thermo Fisher Scientific Ranks 98th in Trading Volume with 10.51 Billion as Stock Price Surges 2.08 - AInvest
Thermo Fisher Acquires Sanofi’s Ridgefield Facility to Produce Essential Medicines - geneonline.com
Thermo Fisher Scientific's Options: A Look at What the Big Money is Thinking - Nasdaq
Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site - Genetic Engineering and Biotechnology News
Thermo Fisher Scientific, SAMRC, DSTI launch new scientific training facility - Engineering News
Thermo Fisher to Acquire Sanofi's Ridgefield Sterile Manufacturing Site - PharmiWeb.com
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - BioSpace
Thermo Fisher to acquire Sanofi’s steriles manufacturing site in US to produce critical medicines - BioSpectrum Asia
Thermo Fisher Scientific Inc. Ranks 83rd in Trading Volume with 11.51 Billion Shares Exchanged Amid Acquisition News and Strong Financial Results - AInvest
Thermo Fisher and Sanofi Expand Partnership to Enable Manufacturing - New Jersey Business Magazine
Thermo Fisher Scientific price target lowered to $550 by TD Cowen - Investing.com
Sanofi, Thermo Fisher announce partnership to boost US manufacturing - WFMZ.com
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Thermo Fisher acquires Sanofi’s New Jersey manufacturing site By Reuters - Investing.com
Thermo Fisher Acquires Sanofi's New Jersey Manufacturing Site - US News Money
Thermo Fisher Scientific, Sanofi Expand Strategic Partnership - Contract Pharma
Thermo Fisher Scientific Signs Deal To Buy Sanofi's Steriles Manufacturing Site In Ridgefield - Nasdaq
Thermo Fisher to buy Sanofi's U.S. production site (TMO:NYSE) - Seeking Alpha
Thermo Fisher to acquire Sanofi’s sterile manufacturing site in New Jersey - Investing.com
Thermo Fisher Scientific introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System - SelectScience
Thermo Fisher Scientific's Trading Volume Drops 26.9% Ranking 96th Amid Manufacturing Expansion and Innovation Push - AInvest
Thermo Fisher Scientific (TMO) Unveils Next-Day Genomic Profiling With Oncomine Assay Plus - Yahoo Finance
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
1.22%
자본화:
|
볼륨(24시간):